1st Constitution Bank (FCCY), 2650 Route 130 North, Constitution Center, Box 634, Cranbury 08512-0634; 609-655-4500; fax, 609-655-5653. Robert F. Mangano, president and CEO. www.1stconstitution.com.
1st Constitution Bancorp, the parent company of First Constitution Bank, has bought Rumson-Fair Haven Bank and Trust Company for $23 million.
Rumson, headquartered in Rumson, had five branches and $214 million in assets. The combined entity now has about $1.0 billion in assets.
1st Constitution Bancorp, through its primary subsidiary, 1st Constitution Bank, operates 14 branch banking offices.
AmeriHealth NJ, 259 Prospect Plains Road, Building M, Cranbury 08512; 609-662-2454; fax, 609-662-2360. Judith Roman, president. www.amerihealth.com.
AmeriHealth New Jersey, an HMO based in Cranbury, has signed a contract with healthcare provider Kennedy Health Alliance to define new quality metrics aimed at improving care and lowering costs. Terms were not disclosed.
The program is meant to reduce readmissions. The system includes a discharge management component as well as measures to ensure preventative care is consistent throughout Kennedy offices.
Celsion Corp., 997 Lenox Drive, Suite 100, Lawrenceville 08648; 800-262-0394; fax. Gregory Weaver, senior VP, CFO. www.celsion.com.
Lawrenceville-based drugmaker Celsion Corporation has signed a deal with Chinese firm Zhejiang Hisun Pharmaceutical Company to work together on developing a cancer drug called ThermoDoxr. In June 2012, Celsion and Hisun signed a long-term commercial supply agreement for the production of Celsion’s ThermoDoxr.
Hisun is one the largest manufacturers of chemotherapy agents globally. Under the terms of the deal, Hisun will manufacture the drug. A press release by Celsion said using a local partenr provides advantages in getting the drug approved by government regulators in the Chinese market. Michael H. Tardugno, Celsion’s president and CEO said Hisun represents an ideal strategic partner due to their regulatory and manufacturing expertise. “We will work very closely with Hisun to accelerate our drug development program in China for ThermoDoxr in primary liver cancer and other indications,” he said.
ThermoDoxr is an injectible drug that targets a variety of cancers, and is unique due to the fact that it is administered at high temperatures of 42 degres celcius. It is currently undergoing late clinical trials for FDA approval.
Princeton Partners Inc., 205 Rockingham Way, Princeton 08540-5760; 609-452-8500; fax, 609-452-7212. Thomas M. Sullivan, CEO and owner. www.princetonpartners.com.
New Jersey’s Office of Homeland Security and Preparedness has re-hired PR firm Princeton Partners to support its PR efforts, according to a press account. The agency’s new three-year contract is worth up to $4 million. Leaving Town
Biogensys, 666 Plainsboro Road, Suite 214, Plainsboro. www.biogensys.com.
High-tech staffing company Biogensys has closed its Plainsboro Road office. A person answering the phone at the company’s listed number said it was not the number for Biogensys.
Lloyd Group, 7 Witherspoon Street, Princeton 08542; 609-269-2315; fax, 212-221-0459. Adam Lloyd Eiseman, president & CEO. www.lloydgroup.com.
Manhattan-based IT consulting firm Lloyd Group has moved its Princeton office from Tulane Street to Witherspoon Street.
KB Financial Partners LLC, 214 Carnegie Center, Suite 110, Princeton 08540; 609-514-4710; fax, 609-514-4739. Alan M. Tofig, vice president.
Financial planning company Karr-Barth Associates has changed its name to KB Financial Partners LLC.